Thomas J Klima, an officer at Bluebird Bio, Inc., is set to sell 1,006 common shares of the company on 09/30/2024, as per the latest filing. The shares to be sold were part of a larger acquisition of 2,750 shares on 09/01/2022, which were obtained as restricted stock units that vested and are being sold due to withholding taxes. The transaction is part of a pre-planned trading arrangement set on 05/10/2023. No other sales have been reported in the past three months.

Thomas J Klima, an officer at Bluebird Bio, Inc., is set to sell 1,006 common shares of the company on 09/30/2024, as per the latest filing. The shares to be sold were part of a larger acquisition of 2,750 shares on 09/01/2022, which were obtained as restricted stock units that vested and are being sold due to withholding taxes. The transaction is part of a pre-planned trading arrangement set on 05/10/2023. No other sales have been reported in the past three months.